Clinical Trial: A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07601048) titled 'A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment' on May 15.

Brief Summary: The study is being conducted to evaluate the efficacy, and safety of HRS-7058 in KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment

Intervention: DRUG: HRS-7058

HRS-7058

DRUG: Fulzerasib Tablets

600mg BID

DRUG: Garsorasib Tablets

600mg BID

DRU...